OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,523 | -22.3% | 13,157 | -33.7% | 0.00% | – |
| Q2 2023 | $65,059 | -77.5% | 19,835 | -72.4% | 0.00% | – |
| Q1 2021 | $289,000 | +74.1% | 71,956 | 0.0% | 0.00% | – |
| Q4 2020 | $166,000 | -55.4% | 71,956 | +11.1% | 0.00% | -100.0% |
| Q3 2020 | $372,000 | -21.8% | 64,757 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $476,000 | +1222.2% | 64,550 | +220.2% | 0.00% | – |
| Q1 2019 | $36,000 | -26.5% | 20,162 | 0.0% | 0.00% | – |
| Q4 2018 | $49,000 | -57.0% | 20,162 | 0.0% | 0.00% | – |
| Q3 2018 | $114,000 | -27.4% | 20,162 | 0.0% | 0.00% | – |
| Q2 2018 | $157,000 | +18.9% | 20,162 | +8.0% | 0.00% | – |
| Q1 2018 | $132,000 | +50.0% | 18,676 | +109.8% | 0.00% | – |
| Q4 2017 | $88,000 | +15.8% | 8,900 | 0.0% | 0.00% | – |
| Q3 2017 | $76,000 | -18.3% | 8,900 | 0.0% | 0.00% | – |
| Q2 2017 | $93,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,252,892 | $10,930,000 | 4.97% |
| GLOBEFLEX CAPITAL L P | 1,397,770 | $4,697,000 | 1.02% |
| BVF INC/IL | 6,631,051 | $22,280,000 | 0.87% |
| EcoR1 Capital, LLC | 6,082,200 | $20,436,000 | 0.71% |
| Ikarian Capital, LLC | 1,105,082 | $3,715,000 | 0.26% |
| CHI Advisors LLC | 233,510 | $785,000 | 0.23% |
| DCF Advisers, LLC | 141,701 | $476,000 | 0.21% |
| Artal Group S.A. | 2,500,000 | $8,400,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,577,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 1,903,162 | $6,394,000 | 0.02% |